Glucotrack, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$16.1M | -$14.5M | -$7.1M | -$4.4M | -$4.0M |
| Operating expenses | $16.1M | $14.5M | $7.1M | $4.4M | $4.0M |
| Cash from operations | -$15.2M | -$12.5M | -$6.6M | -$3.7M | -$3.8M |
| Capital expenditure | $96,000 | $104,000 | — | $1,000 | $5,000 |
| Free cash flow | -$15.3M | -$12.6M | — | -$3.7M | -$3.8M |
| Total assets | $7.8M | $5.9M | $4.9M | $2.4M | $6.3M |
| Total liabilities | $5.0M | $18.9M | $1.7M | $1.2M | $1.1M |
Shares outstanding 6.3M · Free float 55.8%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.